G Thomas Wiggans

Affiliations

  • at Annexon Inc. (ANNX), 2025-06-09
  • Director at Jasper Therapeutics Inc. (JSPR), 2024-06-10
  • at Cymabay Therapeutics Inc. (CBAY), 2024-03-22
  • Chief Executive Officer at Pardes Biosciences Inc. (PRDS), 2023-08-31
  • Director at Forma Therapeutics Holdings Inc. (FMTX), 2022-10-14
  • Ceo & Chairman Of The Board at Dermira Inc. (DERM), 2020-02-25
  • Director at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
  • Director at Somaxon Pharmaceuticals Inc. (SOMX), 2012-07-03
  • Director at Sangamo Biosciences Inc (SGMO), 2011-06-03
  • Officer, Director at Peplin Inc (PLI), 2009-01-15
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JSPR $0.65 10,000 $6,486.00 50,000 2023-11-28 Filing
JSPR $0.64 10,000 $6,383.00 40,000 2023-11-21 Filing
JSPR $0.63 10,000 $6,309.00 30,000 2023-11-20 Filing
JSPR $0.60 10,000 $5,966.00 20,000 2023-11-17 Filing
JSPR $0.60 10,000 $5,965.00 10,000 2023-11-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DERM $27.51 5,000 $137,565.50 13,662 2017-12-13 Filing
DERM $27.52 5,000 $137,608.00 13,427 2017-11-02 Filing
DERM $27.52 5,000 $137,606.00 13,427 2017-10-10 Filing
DERM $27.51 9,500 $261,335.50 13,427 2017-09-18 Filing
DERM $27.58 500 $13,790.70 7,690 2017-08-01 Filing